Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. VANCOUVER, BC / ACCESSWIRE / March 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development…


Previous articlePsychedelic vs. Hallucinogen-What’s in a Name?
Next articlePTSF52 – Start Low, Go Slow